SPARC and central nervous system cancer: Gliomas highly express transferrin receptor and albumin-binding receptor SPARC, while M2 TAMs also highly express SPARC and mannose, therefore facilitating the dual-targeting role of these nanoparticles for both gliomas and M2 TAMs.